Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma

Clinical trial NCT00568308 · TERMINATED

Trial details

NCT number: NCT00568308
Sponsor: Progen Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer Liver Cancer Primary Liver Cancer Hepatocellular Carcinoma Hepatoma

Start date: 2007-12-01
Primary completion: 2008-07-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.